LB Pharmaceuticals Inc (LBRX) analyst actions
Rating and price-target actions on LBRX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LBRX overview →
2 measured LBRX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia | Press release | +1.28% | +2.93% | |
| LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program | Press release | -1.23% | -6.75% |
Keep exploring
More LBRX: earnings → · SEC filings → · LBRX overview →